Women Engaging in Quitting Smoking Together

Study Overview
=================
Brief Summary
-----------------
The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education (HE) comparison intervention, in which both groups also receive standard behavioral smoking cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking outcomes at 1-, 3-, and 6-month follow-ups.

Official Title
-----------------
Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women

Conditions
-----------------
Smoking Cessation

Intervention / Treatment
-----------------
* Behavioral: Distress Tolerance Treatment for Weight Concern (DT-W)
* Behavioral: Health Education (HE)
* Behavioral: Smoking Cessation counseling
* Drug: Transdermal Nicotine Patch


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: female at least 18 years of age smoke 5 or more cigarettes per day daily smoker for at least the past year report motivation to quit smoking in the next month of at least 5 on a 10 point scale report concern of at least 50 on at least one of two 100 point scales assessing weight concern able to travel to study location for study appointments Exclusion Criteria: current use of other smoking cessation or weight loss therapies current use of other tobacco products at least weekly diagnosis or treatment for non-nicotine substance use disorder with substance use during the past 6 months lifetime diagnosis or treatment of eating disorder, bipolar disorder, schizophrenia, or schizoaffective disorder score above established cut-offs on self-report screening measures of depressive symptomology, eating disorder symptomology, alcohol use disorder, or drug use disorder current suicidality or homicidality medical condition that is a contraindication for the use of transdermal nicotine patch lives at same address as current or past participant

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Distress Tolerance Treatment for Weight Concern (DT-W)<br>DT-W is delivered over a 9 week period with 1 1-hr individual session during week 1, 8 weekly 1.5-hr group counseling sessions during weeks 2-9, and 1 20-minute individual telephone session during week 4. Session content includes distress tolerance intervention for weight concern plus standard behavioral smoking cessation treatment. Participants also receive 8 weeks of nicotine patch. | Behavioral: Distress Tolerance Treatment for Weight Concern (DT-W)<br> <br> Behavioral: Smoking Cessation counseling<br> <br> Drug: Transdermal Nicotine Patch<br> <br> |
| Active Comparator: Health Education (HE)<br>HE is delivered over a 9 week period with 1 1-hr individual session during week 1, 8 weekly 1.5-hr group counseling sessions during weeks 2-9, and 1 20-minute individual telephone session during week 4. Session content includes smoking health education program plus standard behavioral smoking cessation treatment. Participants also receive 8 weeks of nicotine patch. | Behavioral: Health Education (HE)<br> <br> Behavioral: Smoking Cessation counseling<br> <br> Drug: Transdermal Nicotine Patch<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Point prevalence abstinence from smoking: percentage of participants in each treatment group who report abstinence from smoking for the 7 days prior to each follow-up assessment | The investigators will compare the percentage of participants in each treatment group who report abstinence from smoking for the 7 days prior to each follow-up assessment (1-, 3-, and 6-months post-quit date). | 6 months post-quit date |